Comparison of warfarin time in the therapeutic range at a pharmacist-run anticoagulation clinic and the RE-LY trial.
CONCLUSION: TTR values among PAC-managed patients with nonvalvular atrial fibrillation were comparable to those reported in the RE-LY trial.
PMID: 25788509 [PubMed - in process]
Source: American Journal of Health-System Pharmacy : AJHP - Category: Drugs & Pharmacology Authors: Biszewski M, Nitzki-George D, Zhou Y Tags: Am J Health Syst Pharm Source Type: research
More News: Atrial Fibrillation | Cardiology | Congestive Heart Failure | Coumadin | Diabetes | Drugs & Pharmacology | Endocrinology | Health | Heart | Heart Failure | Hypertension | Pradaxa | Stroke | Warfarin